Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):623-32. doi: 10.1586/17474124.2014.906899. Epub 2014 Apr 24.
Acute-on-chronic hepatitis B liver failure is a devastating condition that is associated with mortality rates of over 50% and is consequent to acute exacerbation of chronic hepatitis B in patients with previously diagnosed or undiagnosed chronic liver disease. Liver transplantation is the definitive treatment to lower mortality rate, but there is a great imbalance between donation and potential recipients. An early and accurate prognostic system based on the integration of laboratory indicators, clinical events and some mathematic logistic equations is needed to optimize treatment for patients. As parts of the scoring systems, the MELD was the most common and the donor-MELD was the most innovative for patients on the waiting list for liver transplantation. This review aims to highlight the various features and prognostic capabilities of these scoring systems.
慢加急性乙型肝炎肝衰竭是一种破坏性疾病,其死亡率超过 50%,是由先前诊断或未诊断的慢性肝病患者的慢性乙型肝炎急性加重引起的。肝移植是降低死亡率的确定性治疗方法,但供体与潜在受者之间存在巨大的不平衡。需要一种基于实验室指标、临床事件和一些数学逻辑方程整合的早期、准确的预后系统,以优化患者的治疗。作为评分系统的一部分,MELD 是最常见的,而供体-MELD 是最具创新性的,适用于等待肝移植的患者。本综述旨在强调这些评分系统的各种特征和预后能力。